130 related articles for article (PubMed ID: 33634019)
1. ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Wang J; Yang S; Min L; Zhu S; Guo S; Zhang S
Front Oncol; 2020; 10():589241. PubMed ID: 33634019
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.
Li C; Peng Z; Wang Y; Lam G; Nissen N; Tang J; Yuan X; Lewis M; Greene MI; Pandol SJ; Wang Q
Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G380-G395. PubMed ID: 33501895
[TBL] [Abstract][Full Text] [Related]
3. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
4. Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer.
Frontiers Editorial Office
Front Oncol; 2021; 11():734761. PubMed ID: 34350126
[TBL] [Abstract][Full Text] [Related]
5. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
[TBL] [Abstract][Full Text] [Related]
6. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [
